<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药云端工作室 | wechat-feeds</title><link>http://MjM5NDEwMDQ2Mg.favicon.privacyhide.com/favicon.ico</link><description>医药行业领先的智库，连接政策与市场的桥梁</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 06 Apr 2021 19:20:08 +0800</pubDate><image><url>http://MjM5NDEwMDQ2Mg.favicon.privacyhide.com/favicon.ico</url><title>医药云端工作室 | wechat-feeds</title><link>http://MjM5NDEwMDQ2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>头孢呋辛、阿卡米星修订说明书，或影响70亿市场</title><link>https://mp.weixin.qq.com/s/D6tFLrqNBK3kt7-Tirhrdw</link><description></description><content:encoded><![CDATA[头孢呋辛、阿卡米星修订说明书，或影响70亿市场]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:56 +0800</pubDate></item><item><title>集采“四连环”：报量-报价-市场选择-标后攻防，通盘考量，统一规划</title><link>https://mp.weixin.qq.com/s/t7e3RSTuq1xSyW252ACbBA</link><description></description><content:encoded><![CDATA[集采“四连环”：报量-报价-市场选择-标后攻防，通盘考量，统一规划]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:56 +0800</pubDate></item><item><title>666个国采通用名药品，将联动降价（附名单）</title><link>https://mp.weixin.qq.com/s/HTdQAlHFL2Xgv1wN-QRkYQ</link><description></description><content:encoded><![CDATA[666个国采通用名药品，将联动降价（附名单）]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:56 +0800</pubDate></item><item><title>哈药集团巨亏超10亿元，投资健安喜也破产了！</title><link>https://mp.weixin.qq.com/s/I9AcCw5LDLOqQ4enbp8EzQ</link><description></description><content:encoded><![CDATA[哈药集团巨亏超10亿元，投资健安喜也破产了！]]></content:encoded><pubDate>Tue, 06 Apr 2021 18:57:56 +0800</pubDate></item><item><title>涉嫌原料药垄断，知名药企被罚4402万！</title><link>https://mp.weixin.qq.com/s/dY7xMec3VDQeJwPFh1CzAQ</link><description></description><content:encoded><![CDATA[涉嫌原料药垄断，知名药企被罚4402万！]]></content:encoded><pubDate>Mon, 05 Apr 2021 08:28:24 +0800</pubDate></item><item><title>带量采购是一场“持久战”，别再梦游，投入资源，战斗！</title><link>https://mp.weixin.qq.com/s/NwAALYZgeZ5xwqyCTK_H4Q</link><description></description><content:encoded><![CDATA[带量采购是一场“持久战”，别再梦游，投入资源，战斗！]]></content:encoded><pubDate>Mon, 05 Apr 2021 08:28:24 +0800</pubDate></item><item><title>生物药企研发费用大比拼，烧钱速度不亚于互联网公司，百济神州、复宏汉霖、再鼎、基石药业......</title><link>https://mp.weixin.qq.com/s/mJwcm1dtxuMOSlmLjLjtzQ</link><description></description><content:encoded><![CDATA[生物药企研发费用大比拼，烧钱速度不亚于互联网公司，百济神州、复宏汉霖、再鼎、基石药业......]]></content:encoded><pubDate>Mon, 05 Apr 2021 08:28:24 +0800</pubDate></item><item><title>82个品种满足第五批集采要求！持续跟踪109周，本周21个品种通过（视同）一致性评价</title><link>https://mp.weixin.qq.com/s/NoO80Ce9XIKfjg5MdyniYw</link><description></description><content:encoded><![CDATA[82个品种满足第五批集采要求！持续跟踪109周，本周21个品种通过（视同）一致性评价]]></content:encoded><pubDate>Sun, 04 Apr 2021 17:30:35 +0800</pubDate></item><item><title>医保结余留用政策有变；长处方首推基药集采等品种；福建69个重点监控关注品种公布｜云端周报</title><link>https://mp.weixin.qq.com/s/d8fcUxDq9r9EAJT2okvHjQ</link><description></description><content:encoded><![CDATA[医保结余留用政策有变；长处方首推基药集采等品种；福建69个重点监控关注品种公布｜云端周报]]></content:encoded><pubDate>Sun, 04 Apr 2021 17:30:35 +0800</pubDate></item><item><title>清明节：45个注射剂价格有争议？河北再调整！</title><link>https://mp.weixin.qq.com/s/TOh3K0ct2NmeLQb6eV7gQA</link><description></description><content:encoded><![CDATA[清明节：45个注射剂价格有争议？河北再调整！]]></content:encoded><pubDate>Sun, 04 Apr 2021 17:30:35 +0800</pubDate></item><item><title>221个国谈药品，这下可以进院了吧？（附品种清单、调查）</title><link>https://mp.weixin.qq.com/s/dZSIXupUym1DXe3gp6GPgw</link><description></description><content:encoded><![CDATA[221个国谈药品，这下可以进院了吧？（附品种清单、调查）]]></content:encoded><pubDate>Sat, 03 Apr 2021 13:50:02 +0800</pubDate></item><item><title>京津冀“3+N”联盟药品集采开启，11品种纳入</title><link>https://mp.weixin.qq.com/s/_izybSTcSWmLE-DvcySVEA</link><description></description><content:encoded><![CDATA[京津冀“3+N”联盟药品集采开启，11品种纳入]]></content:encoded><pubDate>Sat, 03 Apr 2021 13:50:02 +0800</pubDate></item><item><title>24708个药品，将联动全国价格</title><link>https://mp.weixin.qq.com/s/zFa02NRiM48o0Dew9WgDgw</link><description></description><content:encoded><![CDATA[24708个药品，将联动全国价格]]></content:encoded><pubDate>Sat, 03 Apr 2021 13:50:02 +0800</pubDate></item><item><title>四川药品采购新变化：集采、联动、备案采购</title><link>https://mp.weixin.qq.com/s/XSx-eGHwe6xB2Amln4XW6A</link><description></description><content:encoded><![CDATA[四川药品采购新变化：集采、联动、备案采购]]></content:encoded><pubDate>Sat, 03 Apr 2021 13:50:02 +0800</pubDate></item><item><title>全球药企营收TOP20：强生、罗氏、诺华位列三甲（附榜单）</title><link>https://mp.weixin.qq.com/s/G-gjyN5md-k2ET2NqPgIDA</link><description></description><content:encoded><![CDATA[全球药企营收TOP20：强生、罗氏、诺华位列三甲（附榜单）]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:12:57 +0800</pubDate></item><item><title>长处方最新规定！优选基药、集采和医保药品，4种情况终止</title><link>https://mp.weixin.qq.com/s/fiux692nc0avXeNgvPuVCA</link><description></description><content:encoded><![CDATA[长处方最新规定！优选基药、集采和医保药品，4种情况终止]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:12:57 +0800</pubDate></item><item><title>三年亏79亿，互联网医疗巨头微医即将IPO</title><link>https://mp.weixin.qq.com/s/lnDm8xOF33MGgTn0KmFHLA</link><description></description><content:encoded><![CDATA[三年亏79亿，互联网医疗巨头微医即将IPO]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:12:57 +0800</pubDate></item><item><title>京东健康：营收近194亿，2000万种商品，1.2万商家</title><link>https://mp.weixin.qq.com/s/KVJwr6IPxy6T47t9u0W7Aw</link><description></description><content:encoded><![CDATA[京东健康：营收近194亿，2000万种商品，1.2万商家]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:12:57 +0800</pubDate></item><item><title>商业三巨头，国控、上药、华润哪家强？</title><link>https://mp.weixin.qq.com/s/Sqy_vsez5Fc6pV2DTfzvDg</link><description></description><content:encoded><![CDATA[商业三巨头，国控、上药、华润哪家强？]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:53:23 +0800</pubDate></item><item><title>“医保留余结用”政策有变，不得直接与科室及个人挂钩！</title><link>https://mp.weixin.qq.com/s/SbBg5QptQGwUXSFmGktPFA</link><description></description><content:encoded><![CDATA[“医保留余结用”政策有变，不得直接与科室及个人挂钩！]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:53:23 +0800</pubDate></item></channel></rss>